BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9308012)

  • 1. Cyclin-dependent protein kinase 5 activity increases in rat brain following ischemia.
    Green SL; Kulp KS; Vulliet R
    Neurochem Int; 1997 Oct; 31(4):617-23. PubMed ID: 9308012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract.
    Hosoi T; Uchiyama M; Okumura E; Saito T; Ishiguro K; Uchida T; Okuyama A; Kishimoto T; Hisanaga S
    J Biochem; 1995 Apr; 117(4):741-9. PubMed ID: 7592534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Grundke-Iqbal I; Iqbal K; Bogdanovic N; Winblad B; Cowburn RF
    Brain Res; 1998 Jun; 797(2):267-77. PubMed ID: 9666145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.
    Bennecib M; Gong CX; Grundke-Iqbal I; Iqbal K
    FEBS Lett; 2000 Nov; 485(1):87-93. PubMed ID: 11086171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
    Shelton SB; Krishnamurthy P; Johnson GV
    J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, function, and regulation of neuronal Cdc2-like protein kinase.
    Lew J; Qi Z; Huang QQ; Paudel H; Matsuura I; Matsushita M; Zhu X; Wang JH
    Neurobiol Aging; 1995; 16(3):263-8; discussion 268-70. PubMed ID: 7566336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5.
    Baumann K; Mandelkow EM; Biernat J; Piwnica-Worms H; Mandelkow E
    FEBS Lett; 1993 Dec; 336(3):417-24. PubMed ID: 8282104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
    Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
    Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells.
    Zheng YL; Li BS; Amin ND; Albers W; Pant HC
    Eur J Biochem; 2002 Sep; 269(18):4427-34. PubMed ID: 12230554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.
    Sengupta A; Wu Q; Grundke-Iqbal I; Iqbal K; Singh TJ
    Mol Cell Biochem; 1997 Feb; 167(1-2):99-105. PubMed ID: 9059986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule.
    Kobayashi S; Ishiguro K; Omori A; Takamatsu M; Arioka M; Imahori K; Uchida T
    FEBS Lett; 1993 Dec; 335(2):171-5. PubMed ID: 8253190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.
    Li T; Hawkes C; Qureshi HY; Kar S; Paudel HK
    Biochemistry; 2006 Mar; 45(10):3134-45. PubMed ID: 16519508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.
    Tsai LH; Delalle I; Caviness VS; Chae T; Harlow E
    Nature; 1994 Sep; 371(6496):419-23. PubMed ID: 8090221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A brain-specific activator of cyclin-dependent kinase 5.
    Lew J; Huang QQ; Qi Z; Winkfein RJ; Aebersold R; Hunt T; Wang JH
    Nature; 1994 Sep; 371(6496):423-6. PubMed ID: 8090222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death.
    Alvarez A; Toro R; Cáceres A; Maccioni RB
    FEBS Lett; 1999 Oct; 459(3):421-6. PubMed ID: 10526177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5.
    Brion JP; Couck AM
    Am J Pathol; 1995 Nov; 147(5):1465-76. PubMed ID: 7485409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK5-mediated tau accumulation triggers methamphetamine-induced neuronal apoptosis via endoplasmic reticulum-associated degradation pathway.
    Xiao N; Zhang F; Zhu B; Liu C; Lin Z; Wang H; Xie WB
    Toxicol Lett; 2018 Aug; 292():97-107. PubMed ID: 29705343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cyclin-dependent kinase 5/p35(nck5a) in the synaptic reorganization of rat hippocampus during kindling progression.
    Tomizawa K; Cai XH; Moriwaki A; Matsushita M; Matsui H
    Jpn J Physiol; 2000 Oct; 50(5):525-32. PubMed ID: 11120919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.